HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway
-
Add time:07/12/2019 Source:sciencedirect.com
BackgroundDrug therapy plays an important role in the treatment of cervical cancer, which is one of the most common solid tumors in women. Therefore, it is important to seek more effective and less toxic therapies.
We also recommend Trading Suppliers and Manufacturers of 2-(4-BROMO-PHENYL)-IMIDAZO[1,2-A]PYRIMIDINE (cas 56921-85-8). Pls Click Website Link as below: cas 56921-85-8 suppliers
Prev:Molar volumes and viscosities of N-[(4-bromo-3,5-difluorine)phenyl] maleimide (BDPM)-DMF-toluene and BDPM-DMF-ethanol mixtures in a range 298 to 318 K
Next:Synthesis and molecular structure of 2-bromo-N-(4-(7-(diethylamino)-coumarin-3-yl)phenyl)propanamide: New coumarin-based fluorescent ATRP initiator) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Solubilities of N-[(4-bromo-3,5-difluorine) phenyl]-acrylamide in methanol–ethanol solution07/15/2019
- Crystal structure and spectroscopic characterization of (E)-2-(((4-bromo-2-(trifluoromethoxy)phenyl)imino)methyl)-4-nitrophenol: A combined experimental and computational study07/14/2019
- Synthesis and molecular structure of 2-bromo-N-(4-(7-(diethylamino)-coumarin-3-yl)phenyl)propanamide: New coumarin-based fluorescent ATRP initiator07/13/2019
- Molar volumes and viscosities of N-[(4-bromo-3,5-difluorine)phenyl] maleimide (BDPM)-DMF-toluene and BDPM-DMF-ethanol mixtures in a range 298 to 318 K07/11/2019
